相关实验视频
Updated: Jan 12, 2026

19:50
Interview: Protein Folding and Studies of Neurodegenerative Diseases
Published on: July 16, 2008
13.2K
通过共同蛋白质病变的透镜重新思考神经退行
Yu P Zhang1, Shekhar Kedia1, David Klenerman1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK; UK Dementia Research Institute at Cambridge, Cambridge CB2 0XY, UK.
Trends in neurosciences
|November 7, 2025
概括
神经退行性疾病涉及多个错误折叠的蛋白质之间的复杂相互作用,而不仅仅是单一的罪祸首. 一个新的共同蛋白质病理框架为了解和治疗这些疾病提供了更现实的方法.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 神经退行性疾病传统上被视为不同的蛋白质病变,专注于单个蛋白质,如粉样蛋白-β,,α-synuclein,或TDP-43.
- 基于这种单一蛋白质范式的几十年的治疗开发已经产生了适度的临床结果.
- 新出现的证据表明,蛋白质聚合物经常共存和相互作用,影响彼此的病原性.
研究的目的:
- 为了解神经退行症提出一个新的共同蛋白质病变框架.
- 从孤立的蛋白质疾病转变为错误折叠的蛋白质的交互网络.
- 倡导研究方法,以捕捉神经退行性疾病中蛋白质相互作用的复杂性.
主要方法:
- 关于神经退行性疾病中蛋白质聚合现有文献的综述.
- 共同蛋白质病理框架的概念发展.
- 强调需要使用多重量化量化技术.
- 突出高级疾病模型的重要性.
主要成果:
- 单一蛋白质模式不足以解释神经退行症的复杂性.
- 蛋白质聚合物以类似网络的方式相互作用和调节病原性.
- 一个共同蛋白质病变框架提供了更准确的疾病机制的表现.
结论:
- 神经退行症应该被视为一种共同蛋白质病变,一种错误折叠的蛋白质的交互网络.
- 这种框架需要多重蛋白质量化和更复杂的疾病模型.
- 共同蛋白质病变的观点为开发更有效的下一代神经退行性治疗提供了基础.
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K
Proteins: From Genes to Degradation
14.0K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.0K
Proteins: From Genes to Degradation
4.2K
4.2K

